IONS vs SRCE · rev $226.6M vs P/E 12, $1.61B cap
Ionis Pharmaceuticals Inc (IONS) versus 1st Source Corporation (SRCE) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
1st Source Corporation (SRCE) is a banks - regional company listed on US.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
SRCE does not have a complete income-statement cache yet.
IONS currently screens at market cap $12.28B. SRCE currently screens at market cap $1.61B and trailing P/E 11.5.
Not investment advice. Open the IONS and SRCE stock pages for the full models.
Not investment advice.